Rapt Therapeutics (RAPT) PT Raised to $6 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RAPT Hot Sheet
Price: $58.02 --0%
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 1
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 1
Join SI Premium – FREE
Wells Fargo analyst Yanan Zhu raised the price target on Rapt Therapeutics (NASDAQ: RAPT) to $6.00 (from $4.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Progyny (PGNY) PT Raised to $38 at Citizens After Guidance Raise
- e.l.f. Beauty (ELF) PT Raised to $132 at Raymond James
- Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK312 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
